The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Tomasz Rakowski

Showing 1-7 of 7 articles
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)
Dudek D, Mehran R, Dziewierz A, Brener S, Rakowski T, Brzeziński M, Brodie B, Xu K, Fahy M, Lansky A, Zmudka K, Stone G
November 29, 2013 | 10.4244/EIJV9I7A135
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial
Rakowski T, Dudek D, Dziewierz A, Yu J, Witzenbichler B, Guagliumi G, Kornowski R, Hartmann F, Lansky A, Brener S, Mehran R, Stone G
March 22, 2013 | 10.4244/EIJV8I11A199
From pharmacologically assisted early transfer to a universal primary angioplasty service: the experience of the Małopolska region
Dudek D, Siudak Z, Dziewierz A, Rakowski T
August 25, 2012 | 10.4244/EIJV8SPA9
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation
De Luca G, Gibson CM, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van't Hof A
August 24, 2012 | 10.4244/EIJV8I4A74
Mesh covered stent in ST-segment elevation myocardial infarction
Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski T, Bartus S, Dragan J, Klecha A, Lansky A, Siudak Z, Zmudka K
November 15, 2010
Time-to-reperfusion therapy influences outcome of patients with myocardial infarction subjected to facilitated PCI
Dudek D, Dziewierz A, Rakowski T, El Masri N, Sorysz D, Zalewski J, Legutko J, Zmudka K, Piwowarska W, Dubiel J
November 20, 2005
Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina
Dudek D, Heba G, Legutko J, Chyrchel M, Rakowski T, Kaluza G, Dubiel J
November 20, 2005

Latest news

NEW ISSUE
Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more
September 20, 2021
STATE OF THE ART
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Rafael Beyar et al.
September 20, 2021
AHEAD OF PRINT
ViV TAVI vs repeat SAVR
Monil Majmundar et al.
September 15, 2021
AHEAD OF PRINT
Thrombectomy for ischaemic stroke
Christopher A. Rajkumar et al.
September 10, 2021
EDITORIAL
Walking the tightrope between ischaemia and bleeding
Michelle L. O’Donoghue et al.
September 20, 2021
EDITORIAL
Microvascular dysfunction endotypes and outcomes
Christos V. Bourantas et al.
September 20, 2021
EDITORIAL
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?
Michael Foley et al.
September 20, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke